Factors affecting the chain length of group A streptococci. I. Demonstration of a metabolically active chain-splitting system.

PubWeight™: 2.00‹?› | Rank: Top 2%

🔗 View Article (PMC 2137239)

Published in J Exp Med on October 01, 1960

Authors

R D EKSTEDT, G H STOLLERMAN

Articles cited by this

THE OCCURRENCE OF BACTERIOSTATIC PROPERTIES IN THE BLOOD OF PATIENTS AFTER RECOVERY FROM STREPTOCOCCAL PHARYNGITIS. J Clin Invest (1944) 7.89

Studies on the bacteriophages of hemolytic streptococci. II. Antigens released from the streptococcal cell wall by a phage-associated lysin. J Exp Med (1958) 4.70

BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS. J Exp Med (1945) 4.47

Studies of L forms and protoplasts of group A streptococci. I. Isolation, growth, and bacteriologic characteristics. J Exp Med (1959) 4.35

Chaining and unchaining Streptococcus faecalis; a hypothesis of the mechanism of bacterial cell separation. Nature (1958) 3.89

Long chain formation by strains of group A streptococci in the presence of homologous antiserum: a type-specific reaction. J Exp Med (1957) 3.81

The relative importance of the capsule and the M-antigen in determining colony form of group A streptococci. J Exp Med (1959) 3.41

The active agent in nascent phage lysis of streptococci. J Gen Microbiol (1957) 3.21

Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods. J Exp Med (1958) 3.16

Bacteriologic and immunologic studies on patients with hemolytic streptococcic infections as related to rheumatic fever. Arch Intern Med (Chic) (1948) 3.07

Factors affecting the chain length of group A streptococci. II. Quantative M-anti-M relationships in the long chain test. J Exp Med (1960) 1.68

Evaluation of the "long chain reaction" as a means for detecting type-specific antibody to group a streptococci in human sera. J Exp Med (1959) 1.63

Articles by these authors

Long chain formation by strains of group A streptococci in the presence of homologous antiserum: a type-specific reaction. J Exp Med (1957) 3.81

Prophylaxis against group A streptococcal infections in rheumatic fever patients; use of new repository penicillin preparation. J Am Med Assoc (1952) 3.51

Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods. J Exp Med (1958) 3.16

Coagulase in reversing antibacterial activity of normal human serum on Micrococcus pyogenes. Proc Soc Exp Biol Med (1955) 3.03

The effect of coagulase on the antibacterial activity of normal human serum against selected strains of Micrococcus pyogenes. Ann N Y Acad Sci (1956) 2.73

Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever. Am J Med (1956) 2.62

The use of antibiotics for the prevention of rheumatic fever. Am J Med (1954) 2.06

Studies on staphylococci. I. Effect of serum and coagulase on the metabolism of coagulase positive and coagulase negative strains. J Bacteriol (1959) 2.00

The association of lipoproteins with the inhibition of streptolysin S by serum. J Clin Invest (1950) 1.79

Factors affecting the chain length of group A streptococci. II. Quantative M-anti-M relationships in the long chain test. J Exp Med (1960) 1.68

Evaluation of the "long chain reaction" as a means for detecting type-specific antibody to group a streptococci in human sera. J Exp Med (1959) 1.63

Further studies on the antibacterial activity of human serum on Micrococcus pyogenes and its inhibition by coagulase. J Bacteriol (1956) 1.63

Prophylaxis against group A streptococci in rheumatic fever; the use of single monthly injections of benzathine penicillin G. N Engl J Med (1955) 1.61

Studies on staphylococci. II. Effect of coagulase on the virulence of coagulase negative strains. J Bacteriol (1960) 1.50

Inhibition of streptolysin S by the serum of patients with rheumatic fever and acute streptococcal pharyngitis. J Clin Invest (1950) 1.47

The influence of rheumatic fever on serum concentrations of the enzyme, glutamic oxalacetic transaminase. Circulation (1955) 1.41

Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms. J Exp Med (1963) 1.41

Determination of C-reactive protein in serum as a guide to the treatment and management of rheumatic fever. Am J Med (1953) 1.34

Studies of streptococcal cell walls. II. Type-specific antigenicity in rabbits. J Bacteriol (1958) 1.24

The use of hemolysin inhibition in the study of experimental and clinical hyperlipemia; the non-specific inhibition of streptolysin O, by serum lipoproteins. J Clin Invest (1954) 1.17

The relationship of Sydenham's chorea to infection with group A streptococci. Am J Med (1956) 1.16

NATURAL RESISTANCE OF GERM-FREE MICE AND COLOSTRUM-DEPRIVED PIGLETS TO GROUP A STREPTOCOCCI. J Immunol (1965) 1.13

Recall of type specific antibodies in man by injections of streptococcal cell walls. J Clin Invest (1962) 1.13

Studies on staphylococci. III. Further studies on purification and mechanism of action of an antibacterial human serum factor. J Bacteriol (1960) 1.11

Serum inhibition of streptococcal diphosphopyridine nucleotidase in uncomplicated streptococcal pharyngitis and in rheumatic fever. J Clin Invest (1959) 1.08

A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. I. Streptococcal infections and recurrences of acute rheumatic fever in the first two years of the study. N Engl J Med (1957) 1.07

Effect of cortisone on passively induced skin hypersensitivity in man. Proc Soc Exp Biol Med (1951) 1.03

RUNT DISEASE INDUCED IN NEONATAL MICE BY STERILE BACTERIAL VACCINES. J Exp Med (1964) 1.02

THE OPSONIC EFFECT OF COMPLEMENT ON THE PHAGOCYTOSIS OF GAMMA-GLOBULIN-COATED BENTONITE PARTICLES. J Immunol (1963) 0.99

The role of the selective throat culture for beta hemolytic streptococci in the diagnosis of acute pharyngitis. Am J Clin Pathol (1962) 0.92

PROTECTION OF A MILITARY POPULATION FROM RHEUMATIC FEVER. ROUTINE ADMINISTRATION OF BENZATHINE PENICILLIN G TO HEALTHY INDIVIDUALS. JAMA (1965) 0.89

RHEUMATIC RECURRENCES IN PATIENTS NOT RECEIVING CONTINUOUS PROPHYLAXIS. JAMA (1964) 0.88

The use of weekly oral doses of sulfamethoxypyridazine for rheumatic fever prevention. J Pediatr (1959) 0.88

STUDIES ON IMMUNITY TO STAPHYLOCOCCAL INFECTION IN MICE. III. A PROTEIN ANTIGEN THAT INDUCES PROTECTION AGAINST CHALLENGE WITH SALINE-SUSPENDED ORGANISMS. J Infect Dis (1964) 0.88

The relationship of streptolysin S inhibitor to phospholipids in the serum of human beings and experimental animals. J Clin Invest (1952) 0.88

Thermolabile factors in human plasma that promote phagocytosis of virulent group A streptococci. Trans Assoc Am Physicians (1961) 0.87

The opsonization of bentonite particles by gamma-globulin. J Immunol (1961) 0.85

Repository benzathine penicillin for the control of rheumatic fever. Bull Rheum Dis (1954) 0.81

The prevention of rheumatic fever by the use of antibiotics. Bull N Y Acad Med (1955) 0.81

Factors that predispose to rheumatic fever. Med Clin North Am (1960) 0.81

The prevention of rheumatic fever. Am Pract Dig Treat (1954) 0.80

Effect of adrenocortical hormones on presence of C-reactive protein in blood. Proc Soc Exp Biol Med (1954) 0.78

Current evaluation of the diagnosis, treatment and prevention of rheumatic fever. Bull Rheum Dis (1962) 0.75

SORE THROAT--A DIAGNOSTIC AND THERAPEUTIC DILEMMA. JAMA (1964) 0.75

[The treatment and prophylaxis of rheumatic fever (acute articular rehumatism]. Doc Geigy Acta Rheumatol (1960) 0.75

NON-TYPE SPECIFIC RESISTANCE TO GROUP A STREPTOCOCCI IN GERM FREE AND CONVENTIONAL MICE. Proc Soc Exp Biol Med (1963) 0.75

The prevention of rheumatic fever. Med Clin North Am (1957) 0.75

Convalescence from acute rheumatic fever as reflected by changes in the ballistocardiograms of 300 children. Trans Am Coll Cardiol (1955) 0.75

RELATIONSHIP BETWEEN STREPTOCOCCAL INFECTION AND FIRST AND RECURRENT ATTACKS OF RHEUMATIC FEVER. Listing Res Cardiovasc Field (1964) 0.75

Potentialities for and limitations in the control of chronic rheumatic fever by prophylactic measures. J Chronic Dis (1955) 0.75

Rheumatic fever. AMA Arch Intern Med (1956) 0.75

A scarlatinal Nachkrankheit of Schick: rheumatic fever, 50 years later. Int Arch Allergy Appl Immunol (1958) 0.75

Procaine penicillin in the treatment of subacute bacterial endocarditis. Am Pract Dig Treat (1949) 0.75

Ballistocardiographic study of body acceleration during the acute and convalescent stages of rheumatic fever. Am Heart J (1955) 0.75

A guide to the use of procaine penicillin in hospital practice. N Y State J Med (1948) 0.75

Rheumatic fever prophylaxis; panel discussion. Antibiot Annu (1958) 0.75

RHEUMATIC DISEASES IN THE USSR. Bull Rheum Dis (1965) 0.75

The etiology and prevention of rheumatic fever. Postgrad Med (1959) 0.75

Streptococcal infections in adolescents and adults after prolonged freedom from rheumatic fever. I. Results of the first three years of the study. N Engl J Med (1960) 0.75

The course of beriberi heart disease in American prisoners-of-war in Japan. Ann Intern Med (1948) 0.75

Immunologic evidence of group A streptococcal infection in patients undergoing mitral commissurotomy. Circulation (1957) 0.75